Search Results - Dongchu Zhou

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Cost-effectiveness analysis of tislelizumab, nivolumab and docetaxel as second- and third-line for advanced or metastatic non-small cell lung cancer in China by Dongchu Zhou, Xia Luo, Zhen Zhou, Xiaohui Zeng, Xiaomin Wan, Chongqing Tan, Qiao Liu

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: